The Drug Enforcement Administration (DEA) published a yearlong extension of telemedicine prescribing flexibilities for ...

DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.

The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year ...

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration system for the remote prescribing of controlled substances. An ...

EXTON, Pa., Sept. 24, 2025 /PRNewswire/ -- ProRx Pharma, the leading health and wellness 503B outsourcing facility, announced today it has been awarded a DEA Controlled Substances Registration ...

The U.S. Drug Enforcement Agency has released its notice of proposed rulemaking for a framework to permit medically necessary controlled substances without an in-person visit without violating the ...

The Drug Enforcement Agency has published a new final rule adjusting the fee schedule for its Diversion Control Program, which includes a more than 30 percent increase in the registration fee assessed ...

The U.S. Drug Enforcement Administration has proposed draft guidance to establish a framework for prescribing controlled substances via telemedicine. The proposal introduces three types of special ...

Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency.

The application follows the Company’s approval from the New Mexico Board of Pharmacy this year. GRANTS, NM, March 07, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (BGXX), a Delaware corporation ...